SG11201803593QA - Engineered nucleic-acid targeting nucleic acids - Google Patents
Engineered nucleic-acid targeting nucleic acidsInfo
- Publication number
- SG11201803593QA SG11201803593QA SG11201803593QA SG11201803593QA SG11201803593QA SG 11201803593Q A SG11201803593Q A SG 11201803593QA SG 11201803593Q A SG11201803593Q A SG 11201803593QA SG 11201803593Q A SG11201803593Q A SG 11201803593QA SG 11201803593Q A SG11201803593Q A SG 11201803593QA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- polynucleotide sequences
- berkeley
- suite
- street
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/51—Physical structure in polymeric form, e.g. multimers, concatemers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/52—Physical structure branched
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562263232P | 2015-12-04 | 2015-12-04 | |
| PCT/US2016/064860 WO2017096328A1 (en) | 2015-12-04 | 2016-12-02 | Engineered nucleic-acid targeting nucleic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201803593QA true SG11201803593QA (en) | 2018-06-28 |
Family
ID=57750577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201803593QA SG11201803593QA (en) | 2015-12-04 | 2016-12-02 | Engineered nucleic-acid targeting nucleic acids |
Country Status (18)
| Country | Link |
|---|---|
| US (4) | US9771600B2 (zh) |
| EP (2) | EP3564371B1 (zh) |
| JP (1) | JP6707133B2 (zh) |
| KR (1) | KR102093570B1 (zh) |
| CN (1) | CN108473981B (zh) |
| AU (2) | AU2016363024B2 (zh) |
| BR (1) | BR112018010429A2 (zh) |
| CA (1) | CA3004757C (zh) |
| DK (1) | DK3371310T3 (zh) |
| ES (1) | ES2735773T3 (zh) |
| HK (1) | HK1252755B (zh) |
| IL (1) | IL259148B (zh) |
| MX (1) | MX2018005392A (zh) |
| NZ (2) | NZ742040A (zh) |
| RU (1) | RU2018117360A (zh) |
| SG (1) | SG11201803593QA (zh) |
| WO (1) | WO2017096328A1 (zh) |
| ZA (1) | ZA201802968B (zh) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9771600B2 (en) | 2015-12-04 | 2017-09-26 | Caribou Biosciences, Inc. | Engineered nucleic acid-targeting nucleic acids |
| IL289989B (en) * | 2016-06-02 | 2022-09-01 | Sigma Aldrich Co Llc | Use of programmable DNA-binding proteins to enhance targeted genome modification |
| US11499151B2 (en) | 2017-04-28 | 2022-11-15 | Editas Medicine, Inc. | Methods and systems for analyzing guide RNA molecules |
| WO2019014564A1 (en) | 2017-07-14 | 2019-01-17 | Editas Medicine, Inc. | SYSTEMS AND METHODS OF TARGETED INTEGRATION AND GENOME EDITING AND DETECTION THEREOF WITH INTEGRATED PRIMING SITES |
| US11584955B2 (en) * | 2017-07-14 | 2023-02-21 | Shanghai Tolo Biotechnology Company Limited | Application of Cas protein, method for detecting target nucleic acid molecule and kit |
| WO2019041296A1 (zh) * | 2017-09-01 | 2019-03-07 | 上海科技大学 | 一种碱基编辑系统及方法 |
| US20200362038A1 (en) * | 2017-09-11 | 2020-11-19 | The Regents Of The University Of California | Antibody-mediated delivery of cas9 to mammalian cells |
| WO2019152941A1 (en) | 2018-02-05 | 2019-08-08 | Caribou Biosciences, Inc. | Engineered gut microbes for reduction of reactivation of detoxified drugs |
| WO2019157326A1 (en) | 2018-02-08 | 2019-08-15 | Zymergen Inc. | Genome editing using crispr in corynebacterium |
| WO2019222545A1 (en) | 2018-05-16 | 2019-11-21 | Synthego Corporation | Methods and systems for guide rna design and use |
| AU2019319377A1 (en) * | 2018-08-09 | 2021-03-11 | G+Flas Life Sciences | Novel CRISPR-associated protein and use thereof |
| CN109517722B (zh) * | 2018-09-28 | 2022-04-01 | 德拜至臻医学科技(杭州)有限公司 | 一种捕获特定微量细胞的装置及其制作和使用方法 |
| EP3864025B1 (en) | 2018-10-12 | 2024-05-08 | Theradaptive, Inc. | Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof |
| WO2020176389A1 (en) | 2019-02-25 | 2020-09-03 | Caribou Biosciences, Inc. | Plasmids for gene editing |
| BR112022008415A2 (pt) | 2019-11-05 | 2022-09-06 | Pairwise Plants Services Inc | Composições e métodos para substituição do dna codificado pelo rna dos alelos |
| US20230203115A1 (en) * | 2020-03-06 | 2023-06-29 | Theradaptive, Inc. | Therapeutic compositions comprising graft materials and beta-tcp binding peptides and uses thereof |
| WO2022256440A2 (en) | 2021-06-01 | 2022-12-08 | Arbor Biotechnologies, Inc. | Gene editing systems comprising a crispr nuclease and uses thereof |
| CN114540325B (zh) * | 2022-01-17 | 2022-12-09 | 广州医科大学 | 靶向dna去甲基化的方法、融合蛋白及其应用 |
| CN116377104B (zh) * | 2022-11-14 | 2024-01-12 | 海南省农业科学院蔬菜研究所 | 一种快菜高温胁迫内参基因及其引物及应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10087431B2 (en) | 2010-03-10 | 2018-10-02 | The Regents Of The University Of California | Methods of generating nucleic acid fragments |
| JP5926242B2 (ja) | 2010-05-10 | 2016-05-25 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | エンドリボヌクレアーゼ組成物およびその使用方法 |
| KR20140066193A (ko) * | 2011-09-01 | 2014-05-30 | 힙 이노베이션 테크놀러지 엘엘씨 | 라이너가 설치된 대퇴골 컵 |
| US9637739B2 (en) * | 2012-03-20 | 2017-05-02 | Vilnius University | RNA-directed DNA cleavage by the Cas9-crRNA complex |
| US10266850B2 (en) * | 2012-05-25 | 2019-04-23 | The Regents Of The University Of California | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription |
| US9688971B2 (en) | 2012-06-15 | 2017-06-27 | The Regents Of The University Of California | Endoribonuclease and methods of use thereof |
| WO2014022702A2 (en) | 2012-08-03 | 2014-02-06 | The Regents Of The University Of California | Methods and compositions for controlling gene expression by rna processing |
| KR102052286B1 (ko) | 2012-10-23 | 2019-12-06 | 주식회사 툴젠 | 표적 DNA에 특이적인 가이드 RNA 및 Cas 단백질을 암호화하는 핵산 또는 Cas 단백질을 포함하는, 표적 DNA를 절단하기 위한 조성물 및 이의 용도 |
| DK3252160T3 (da) | 2012-12-12 | 2021-02-01 | Broad Inst Inc | Systemer, fremgangsmåder og sammensætninger med crispr-cas-bestanddele til sekvensmanipulation |
| JP2016504026A (ja) | 2012-12-12 | 2016-02-12 | ザ・ブロード・インスティテュート・インコーポレイテッド | 配列操作のための系、方法および最適化ガイド組成物のエンジニアリング |
| PL2931898T3 (pl) | 2012-12-12 | 2016-09-30 | Le Cong | Projektowanie i optymalizacja systemów, sposoby i kompozycje do manipulacji sekwencją z domenami funkcjonalnymi |
| ES2576126T3 (es) | 2012-12-12 | 2016-07-05 | The Broad Institute, Inc. | Modificación por tecnología genética y optimización de sistemas, métodos y composiciones enzimáticas mejorados para la manipulación de secuencias |
| WO2014093694A1 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| JP2016519652A (ja) * | 2013-03-14 | 2016-07-07 | カリブー・バイオサイエンシーズ・インコーポレイテッド | 核酸ターゲティング核酸の組成物および方法 |
| CA2930877A1 (en) | 2013-11-18 | 2015-05-21 | Crispr Therapeutics Ag | Crispr-cas system materials and methods |
| WO2015089364A1 (en) * | 2013-12-12 | 2015-06-18 | The Broad Institute Inc. | Crystal structure of a crispr-cas system, and uses thereof |
| US20150376587A1 (en) | 2014-06-25 | 2015-12-31 | Caribou Biosciences, Inc. | RNA Modification to Engineer Cas9 Activity |
| AU2016211517B2 (en) * | 2015-01-28 | 2021-05-13 | Caribou Biosciences, Inc. | CRISPR hybrid DNA/RNA polynucleotides and methods of use |
| US9580727B1 (en) * | 2015-08-07 | 2017-02-28 | Caribou Biosciences, Inc. | Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides |
| US9771600B2 (en) * | 2015-12-04 | 2017-09-26 | Caribou Biosciences, Inc. | Engineered nucleic acid-targeting nucleic acids |
-
2016
- 2016-12-02 US US15/368,570 patent/US9771600B2/en active Active
- 2016-12-02 EP EP19171356.9A patent/EP3564371B1/en active Active
- 2016-12-02 KR KR1020187019090A patent/KR102093570B1/ko active IP Right Grant
- 2016-12-02 NZ NZ742040A patent/NZ742040A/en unknown
- 2016-12-02 WO PCT/US2016/064860 patent/WO2017096328A1/en active Application Filing
- 2016-12-02 NZ NZ756843A patent/NZ756843A/en unknown
- 2016-12-02 ES ES16822804T patent/ES2735773T3/es active Active
- 2016-12-02 CN CN201680071016.9A patent/CN108473981B/zh active Active
- 2016-12-02 DK DK16822804.7T patent/DK3371310T3/da active
- 2016-12-02 AU AU2016363024A patent/AU2016363024B2/en active Active
- 2016-12-02 BR BR112018010429-9A patent/BR112018010429A2/pt unknown
- 2016-12-02 CA CA3004757A patent/CA3004757C/en active Active
- 2016-12-02 SG SG11201803593QA patent/SG11201803593QA/en unknown
- 2016-12-02 MX MX2018005392A patent/MX2018005392A/es unknown
- 2016-12-02 RU RU2018117360A patent/RU2018117360A/ru not_active Application Discontinuation
- 2016-12-02 JP JP2018528798A patent/JP6707133B2/ja active Active
- 2016-12-02 EP EP16822804.7A patent/EP3371310B1/en active Active
-
2017
- 2017-09-14 US US15/703,992 patent/US9970029B1/en active Active
-
2018
- 2018-05-03 IL IL259148A patent/IL259148B/en unknown
- 2018-05-04 US US15/971,863 patent/US10100333B2/en active Active
- 2018-05-07 ZA ZA2018/02968A patent/ZA201802968B/en unknown
- 2018-09-19 HK HK18112080.6A patent/HK1252755B/zh unknown
- 2018-10-04 US US16/152,337 patent/US11505808B2/en active Active
-
2019
- 2019-10-07 AU AU2019240724A patent/AU2019240724B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201803593QA (en) | Engineered nucleic-acid targeting nucleic acids | |
| SG11201810179RA (en) | Novel crispr enzymes and systems | |
| SG11201906297QA (en) | Nucleic acids encoding crispr-associated proteins and uses thereof | |
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201803958WA (en) | Nucleic acids encoding repetitive amino acid sequences rich in proline and alanine residues that have low repetitive nucleotide sequences | |
| SG11201809912UA (en) | Hybrid carriers for nucleic acid cargo | |
| SG11201810327XA (en) | Single domain serum albumin binding protein | |
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201808751SA (en) | T cell receptors | |
| SG11201908280SA (en) | "chimeric molecules and uses thereof" | |
| SG11201906147VA (en) | Optimized strategy for exon skipping modifications using crispr/cas9 with triple guide sequences | |
| SG11201810003UA (en) | Using programmable dna binding proteins to enhance targeted genome modification | |
| SG11201908489XA (en) | De novo synthesized combinatorial nucleic acid libraries | |
| SG11201803169WA (en) | Cellulase variants and polynucleotides encoding same | |
| SG11201804400SA (en) | Scalable methods for producing recombinant adeno-associated viral (aav) vector in serum-free suspension cell culture system suitable for clinical use | |
| SG11201804814YA (en) | Materials and methods for delivering nucleic acids to cochlear and vestibular cells | |
| SG11201804086VA (en) | Methods and compositions for nucleic acid analysis | |
| SG11201810048VA (en) | Tri-segmented pichinde viruses as vaccine vectors | |
| SG11201806639VA (en) | New streptococcal proteases | |
| SG11201907769XA (en) | Cd80 variant immunomodulatory proteins and uses thereof | |
| SG11201807636XA (en) | Process for producing a polyacrylamide solution with increased viscosity | |
| SG11201901563UA (en) | De novo synthesized nucleic acid libraries | |
| SG11201909011PA (en) | Niraparib compositions | |
| SG11201907889YA (en) | Glycan-interacting compounds and methods of use | |
| SG11201407866XA (en) | Method for expression of heterologous proteins using a recombinant negative-strand rna virus vector |